Will Post-Transplantation Cell Therapies for Pediatric Patients Become Standard of Care?

Articolo

Data di Pubblicazione:

2015

Tipologia CRIS:

1.1 Articolo in rivista

Keywords:

Adoptive cellular therapy; Chimeric antigen receptor; Pediatrics; Stem cell transplantation; Adolescent; Allografts; Cell- and Tissue-Based Therapy; Child; Child, Preschool; Female; Graft Rejection; Graft vs Host Disease; Hematologic Neoplasms; Humans; Infant; Lymphocyte Transfusion; Male; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Transplantation; Hematology

Elenco autori:

Lankester, Arjan C; Locatelli, Franco; Bader, Peter; Rettinger, Eva; Egeler, Maarten; Katewa, Satyendra; Pulsipher, Michael A.; Nierkens, Stefan; Schultz, Kirk; Handgretinger, Rupert; Grupp, Stephan A.; Boelens, Jaap Jan; Bollard, Catherine M.

Link alla scheda completa:

https://iris.unipv.it/handle/11571/1112787

Pubblicato in:

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Journal

Dati Generali

URL

http://www.bbmt.org/issues

Will Post-Transplantation Cell Therapies for Pediatric Patients Become Standard of Care?

Lankester, Arjan C; Locatelli, Franco; Bader, Peter; Rettinger, Eva; Egeler, Maarten; Katewa, Satyendra; Pulsipher, Michael A.; Nierkens, Stefan; Schultz, Kirk; Handgretinger, Rupert; Grupp, Stephan A.; Boelens, Jaap Jan; Bollard, Catherine M.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Dati Generali

URL